Evidence map›Paper›PMID 42943999›Full record

ArticleViruses2026

Genomic Characterization of 30 Lytic

Daniel A Mora, Trisha Gryder, Lauren L Lessor, Jordyn Michalik-Provasek, Michael J Satlin, Thomas J Walsh, Jason J Gill

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Viruses, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Daniel A MoraInterdisciplinary Graduate Program in Genetics and Genomics, Texas A&M University, College Station, TX 77843, USA.ORCID 0000-0001-5361-8769
Trisha GryderDepartment of Biochemistry & Biophysics, Texas A&M University, College Station, TX 77843, USA.
Lauren L LessorCenter for Phage Technology, Texas A&M University, College Station, TX 77843, USA.
Jordyn Michalik-ProvasekCenter for Phage Technology, Texas A&M University, College Station, TX 77843, USA.
Michael J SatlinTransplantation-Oncology Infectious Diseases Program, Department of Medicine, Weill Cornell Medicine, Cornell University, New York, NY 10065, USA.ORCID 0000-0003-4711-5334
Thomas J WalshTransplantation-Oncology Infectious Diseases Program, Department of Medicine, Weill Cornell Medicine, Cornell University, New York, NY 10065, USA.ORCID 0000-0002-7078-9778
Jason J GillInterdisciplinary Graduate Program in Genetics and Genomics, Texas A&M University, College Station, TX 77843, USA.

Funding

Development of therapeutic bacteriophages against carbapenemase-resistant Klebsiella pneumoniaeR33AI121689 · NIAID · TEXAS A&M AGRILIFE RESEARCH · PI GILL, JASON J., WALSH, THOMAS · 2018 to 2020
$1.4M
Development of therapeutic bacteriophages against carbapenemase-resistant Klebsiella pneumoniaeR21AI121689 · NIAID · TEXAS A&M AGRILIFE RESEARCH · PI GILL, JASON J., WALSH, THOMAS · 2016 to 2017
$470k
National Institute of Allergy and Infectious Diseases AI121689-01NIAID NIH HHS R21 AI121689NIAID NIH HHS R33 AI121689Save our Sick Kids Foundation
6 · The paper itself

Abstract

The emergence and spread of Gram-negative pathogens that are resistant to multiple antibiotic classes pose a global risk to public health. Among such pathogens, carbapenem-resistant strains of

Indexed as

BacteriophagesGenome, ViralKlebsiella pneumoniaeComputational BiologyGenomicsHost SpecificityPhylogenyVirulenceWhole Genome SequencingbacteriophagecharacterizationgenomicsKlebsiella pneumoniae

Identifiers

PMID42943999
PMCPMC13709898

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.